loading page

A phase II clinical trial of infusing haploidentical K562-mb-IL15-41BBL activated and expanded Natural Killer cells as consolidation therapy for pediatric acute myeloblastic leukemia
  • +23
  • Lara Maria Gómez-García,
  • Adela Escudero,
  • Carmen Maestre,
  • José Luis Fuster Soler,
  • Antonia Pascual,
  • José Manuel Vagace Valero,
  • María Vela,
  • Beatriz Ruz,
  • Alfonso Navarro Zapata,
  • Lucía Fernández,
  • Adrián Fernández,
  • Alejandra Leivas,
  • Joaquín Martínez-López,
  • Cristina Ferreras,
  • Raquel De Paz,
  • Miguel Blanquer Blanquer,
  • Víctor Galán,
  • Berta González,
  • Dolores Corral,
  • Luisa Sisinni,
  • Isabel Mirones,
  • Antonio Balas,
  • José Luis Vicario,
  • Paula Valle,
  • Alberto M. Borobia,
  • Antonio Pérez-Martínez
Lara Maria Gómez-García
Hospital Clínico Universitario de Valladolid
Author Profile
Adela Escudero
Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz
Author Profile
Carmen Maestre
Translational Research in Pediatric Oncology, Hematopoietic Transplantation & Cell Therapy, IdiPAZ
Author Profile
José Luis Fuster Soler
Hospital Clinico Universitario Virgen de la Arrixaca
Author Profile
Antonia Pascual
Hospital Regional Universitario Carlos Haya
Author Profile
José Manuel Vagace Valero
Paediatric Haematology Department, Maternal and Children Hospital, Complejo Hospitalario Universitario de Badajoz
Author Profile
María Vela
Translational Research in Pediatric Oncology, Hematopoietic Transplantation & Cell Therapy
Author Profile
Beatriz Ruz
Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz
Author Profile
Alfonso Navarro Zapata
Translational Research in Pediatric Oncology, Hematopoietic Transplantation & Cell Therapy, IdiPAZ
Author Profile
Lucía Fernández
Haematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO)
Author Profile
Adrián Fernández
Haematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO)
Author Profile
Alejandra Leivas
Haematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO)
Author Profile
Joaquín Martínez-López
Haematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO)
Author Profile
Cristina Ferreras
La Paz University Hospital Biomedical Research Foundation, Instituto Universitario de La Paz
Author Profile
Raquel De Paz
Hospital Universitario La Paz
Author Profile
Miguel Blanquer Blanquer
Hospital Clinico Universitario Virgen de la Arrixaca
Author Profile
Víctor Galán
La Paz University Hospital
Author Profile
Berta González
Pediatric Onco-Hematology Department, Hospital Universitario La Paz
Author Profile
Dolores Corral
Universidad Autónoma de Madrid
Author Profile
Luisa Sisinni
Hospital Universitario La Paz
Author Profile
Isabel Mirones
Pediatric Onco-Hematology Department, Hospital Universitario La Paz
Author Profile
Antonio Balas
Centro de Transfusión Comunidad de Madrid
Author Profile
José Luis Vicario
Centro de Trasfusiones de la Comunidad de Madrid
Author Profile
Paula Valle
Clinical Pharmacology Department, Hospital Universitario La Paz
Author Profile
Alberto M. Borobia
Clinical Pharmacology Department, Hospital Universitario La Paz
Author Profile
Antonio Pérez-Martínez
HOSPITAL UNIVERSITARIO LA PAZ
Author Profile